COM:AUROBINDO
Aurobindo Pharma
- Stock
Last Close
1,220.00
22/11 03:50
Market Cap
772.21B
Beta: -
Volume Today
9.06K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Mar '14 | Mar '15 | Mar '16 | Mar '17 | Mar '18 | Mar '19 | Mar '20 | Mar '21 | Mar '22 | Mar '23 | Mar '24 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
net income | 15.33B - | 21.68B 41.46% | 27.22B 25.58% | 30.61B 12.43% | 32.41B 5.89% | 30.91B 4.62% | 37.43B 21.08% | 73.44B 96.19% | 33.73B 54.07% | 26.13B 22.54% | 31.73B 21.45% | |
depreciation and amortization | 3.13B - | 3.33B 6.42% | 3.93B 18.04% | 4.28B 8.92% | 5.58B 30.48% | 6.68B 19.71% | 9.67B 44.73% | 10.55B 9.17% | 11.27B 6.74% | 12.45B 10.48% | 15.22B 22.26% | |
deferred income tax | -8.51B - | -8.00B 5.96% | -12.02B - | -3.40B - | ||||||||
stock based compensation | -1.40M - | 100K 107.14% | 86.20M - | -57.50M - | ||||||||
change in working capital | -10.59B - | -8.42B 20.52% | -7.38B 12.28% | 6.11B 182.75% | -10.69B 274.96% | -15.10B 41.28% | 2.77B 118.33% | -10.67B 485.30% | 15.58B 246.03% | -10.95B 170.29% | -16.75B 52.98% | |
accounts receivables | -202.40M - | -6.56B 3,141.70% | 7.44B 213.40% | -4.11B 155.22% | -4.32B 5.18% | -2.64B 38.86% | ||||||
inventory | -4.38B - | -5.73B 30.86% | -4.77B 16.79% | -2.74B 42.45% | -14.13B 414.82% | -8.86B 37.28% | -5.27B 40.52% | -15.94B 202.40% | 14.98B 193.97% | -9.27B 161.88% | -13.04B 40.68% | |
accounts payables | -3.74B - | 2.96B 179.04% | 1.26B 57.27% | 1.11B 12.47% | 7.08B 539.54% | 5.83B 17.64% | ||||||
other working capital | -6.21B - | -2.69B 56.75% | -2.62B 2.66% | 8.85B 438.55% | 3.44B 61.18% | -2.30B 166.82% | 11.64B 606.92% | -3.44B 129.52% | 3.60B 204.89% | -4.44B 223.12% | -6.90B 55.48% | |
other non cash items | -1.40B - | -4.22B 202.06% | -6.17B 46.28% | 299.90M 104.86% | 246.70M 17.74% | -6.27B 2,641.59% | -6.05B 3.46% | -28.10B 364.24% | -10.41B 62.97% | -299.60M 97.12% | 34.73B 11,693.79% | |
net cash provided by operating activities | 6.46B - | 12.37B 91.37% | 17.60B 42.27% | 32.79B 86.33% | 19.55B 40.38% | 16.22B 17.02% | 43.81B 170.11% | 33.29B 24.02% | 50.16B 50.69% | 23.87B 52.42% | 24.65B 3.27% | |
investments in property plant and equipment | -3.90B - | -7.68B 96.76% | -15.68B 104.11% | -16.94B 8.03% | -15.30B 9.69% | -16.05B 4.93% | -14.31B 10.86% | -18.74B 30.94% | -27.05B 44.34% | -27.20B 0.58% | -35.62B 30.92% | |
acquisitions net | -242.20M - | -6.86B 2,732.49% | 1.38B 120.11% | -1.18B 185.46% | -7.34B 522.26% | -13.20B 79.91% | -1.69B 87.21% | 25.92B 1,636.04% | -6.25B 124.10% | -915.90M 85.34% | 602.80M 165.82% | |
purchases of investments | -463.10M - | -1.88B 305.27% | -1.60B 14.87% | -8.25B 416.30% | -20.14B 144.15% | -257M 98.72% | ||||||
sales maturities of investments | 463.10M - | 1.88B 305.27% | -3.69B 296.37% | 4.62B 225.26% | 23.51B 409.36% | 1.79B 92.38% | ||||||
other investing activites | -4.04B - | 458.10M 111.34% | 501.30M 9.43% | 250.10M 50.11% | 3.07B 1,125.99% | 484.80M 84.19% | 322M 33.58% | 4.09B 1,169.44% | 4.81B 17.70% | -15.03B 412.42% | -11.89B 20.90% | |
net cash used for investing activites | -8.19B - | -14.09B 72.03% | -13.80B 2.02% | -17.87B 29.49% | -19.57B 9.51% | -28.77B 47.01% | -15.68B 45.51% | 5.99B 138.19% | -32.12B 636.43% | -39.78B 23.86% | -45.37B 14.05% | |
debt repayment | -510.80M - | -1.35B 164.72% | -5.88B 334.49% | -9.13B 55.44% | -9.37B 2.61% | -3.94B 57.97% | -2.17B 44.91% | -11.37B 424.02% | -26.37B 131.89% | -56.50M 99.79% | -14.61B 25,763.89% | |
common stock issued | 34.50M - | 67.60M 95.94% | 72M 6.51% | 66.60M 7.50% | 2.30M 96.55% | 600K 73.91% | 1.90M 216.67% | |||||
common stock repurchased | 7.22B - | -8.71B 220.70% | 20.65B 336.97% | 24.73B 19.74% | -15.42B 162.36% | |||||||
dividends paid | -595.50M - | -1.34B - | -1.14B 15.08% | -2.19B 92.54% | -1.46B 33.45% | -1.76B 20.26% | -2.34B 33.43% | -2.64B 12.54% | -4.40B 66.68% | -2.64B 40.02% | ||
other financing activites | 2.25B - | 2.22B 1.40% | -273.60M 112.34% | -232.30M 15.10% | -447.30M 92.55% | -138.60M 69.01% | -127.90M 7.72% | 65.10M 150.90% | -689.10M 1,158.53% | 22.60B 3,379.05% | ||
net cash used provided by financing activities | 1.18B - | 932.10M 20.77% | -198.30M 121.27% | -19.15B 9,558.40% | 8.64B 145.12% | 19.19B 122.07% | -19.47B 201.47% | -13.65B 29.91% | -29.69B 117.56% | 18.14B 161.11% | 10.51B 42.07% | |
effect of forex changes on cash | -1.20M - | 15.10M 1,358.33% | -3M 119.87% | -1.50M 50% | -1.70M 13.33% | 13.80M 911.76% | 47.80M 246.38% | -21.20M 144.35% | 2M 109.43% | -600K 130% | 141.70M 23,716.67% | |
net change in cash | -547.10M - | 3.03B 652.99% | 3.63B 20.13% | -4.24B 216.62% | 8.92B 310.49% | 6.66B 25.39% | 8.71B 30.89% | 25.83B 196.48% | -11.67B 145.19% | 2.30B 119.68% | 18.80B 718.04% | |
cash at beginning of period | 2.03B - | 1.48B 26.99% | 4.61B 211.51% | 7.43B 61.24% | 3.20B 57.01% | 12.10B 278.54% | 18.76B 55.01% | 27.47B 46.45% | 53.30B 94.04% | 41.63B 21.90% | 43.99B 5.68% | |
cash at end of period | 1.48B - | 4.51B 204.39% | 8.25B 83.01% | 3.20B 61.24% | 12.12B 279.14% | 18.76B 54.77% | 27.47B 46.45% | 53.30B 94.04% | 41.63B 21.90% | 43.92B 5.52% | 62.78B 42.94% | |
operating cash flow | 6.46B - | 12.37B 91.37% | 17.60B 42.27% | 32.79B 86.33% | 19.55B 40.38% | 16.22B 17.02% | 43.81B 170.11% | 33.29B 24.02% | 50.16B 50.69% | 23.87B 52.42% | 24.65B 3.27% | |
capital expenditure | -3.90B - | -7.68B 96.76% | -15.68B 104.11% | -16.94B 8.03% | -15.30B 9.69% | -16.05B 4.93% | -14.31B 10.86% | -18.74B 30.94% | -27.05B 44.34% | -27.20B 0.58% | -35.62B 30.92% | |
free cash flow | 2.56B - | 4.69B 83.16% | 1.91B 59.14% | 15.84B 727.72% | 4.25B 73.18% | 166.20M 96.09% | 29.50B 17,650.84% | 14.55B 50.68% | 23.12B 58.88% | -3.34B 114.43% | -10.97B 228.72% |
All numbers in (except ratios and percentages)